Insider Trading disclosures for Journey Medical Corp

The latest disclosure was made by Claude Maraoui in Journey Medical Corp where a trade of 49,271 Common Stock, $0.0001 par value done at an average price of $5.0 was reported to US exchanges on March 11, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Show

Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Claude Maraoui	Director, President & CEO	Sale of securities on an exchange or to another person at price $ 5.01 per share.	11 Mar 2025	49,271	2,003,147	-	5.0	246,848	Common Stock, $0.0001 par value
Claude Maraoui	Director, President & CEO	Sale of securities on an exchange or to another person at price $ 5.01 per share.	06 Mar 2025	14,905	2,052,418	-	5.0	74,674	Common Stock, $0.0001 par value
Claude Maraoui	Director, President & CEO	Sale of securities on an exchange or to another person at price $ 5.04 per share.	06 Mar 2025	25,551	2,067,323	-	5.0	128,777	Common Stock, $0.0001 par value
Claude Maraoui	Director, President & CEO	Sale of securities on an exchange or to another person at price $ 5.13 per share.	03 Mar 2025	18,147	2,092,874	-	5.1	93,094	Common Stock, $0.0001 par value
Claude Maraoui	Director, President & CEO	Sale of securities on an exchange or to another person at price $ 5.04 per share.	03 Mar 2025	28,901	2,111,021	-	5.0	145,661	Common Stock, $0.0001 par value
Claude Maraoui	Director, President & CEO	Sale of securities on an exchange or to another person at price $ 5.19 per share.	03 Mar 2025	23,508	2,139,922	-	5.2	122,007	Common Stock, $0.0001 par value
Joseph Benesch	CFO	Sale of securities on an exchange or to another person at price $ 5.19 per share.	21 Feb 2025	1,365	45,966	-	5.2	7,084	Common Stock, $0.0001 par value
Joseph Benesch	CFO	Sale of securities on an exchange or to another person at price $ 5.47 per share.	01 Aug 2024	9,324	47,331	-	5.5	51,002	Common Stock, $0.0001 par value
Joseph Benesch	CFO	Sale of securities on an exchange or to another person at price $ 5.40 per share.	23 Jul 2024	4,055	56,655	-	5.4	21,897	Common Stock, $0.0001 par value
Michael C. Pearce	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	19 Jul 2024	30,000	30,000	-		0	Common Stock, $0.0001 par value
Justin Smith	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Jul 2024	9,728	144,445	-		0	Common Stock, $0.0001 par value
Miranda Jayne Toledano	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Jul 2024	9,728	81,445	-		0	Common Stock, $0.0001 par value
Neil Herskowitz	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Jul 2024	9,728	81,445	-		0	Common Stock, $0.0001 par value
Lindsay A. Rosenwald	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Jul 2024	9,728	153,973	-		0	Common Stock, $0.0001 par value
Lindsay A. Rosenwald	Director	Purchase of securities on an exchange or from another person at price $ 3.04 per share.	25 Mar 2024	10,000	144,245	-	3.0	30,400	Common Stock, $0.0001 par value
Justin Smith	Director	Purchase of securities on an exchange or from another person at price $ 3.47 per share.	22 Mar 2024	30,000	134,717	-	3.5	104,100	Common Stock, $0.0001 par value
Claude Maraoui	Director, President & CEO	Purchase of securities on an exchange or from another person at price $ 3.48 per share.	22 Mar 2024	10,000	2,163,430	-	3.5	34,790	Common Stock, $0.0001 par value
Lindsay A. Rosenwald	Director	Purchase of securities on an exchange or from another person at price $ 3.40 per share.	22 Mar 2024	20,000	134,245	-	3.4	68,000	Common Stock, $0.0001 par value
Joseph Benesch	Interim CFO	Sale of securities on an exchange or to another person at price $ 3.75 per share.	22 Feb 2024	2,450	60,710	-	3.8	9,188	Common Stock, $0.0001 par value
Paley Jeffrey	Director	Sale of securities on an exchange or to another person at price $ 3.76 per share.	07 Nov 2023	255	114,217	-	3.8	959	Common Stock, par value $0.0001 per share
Jeffrey Paley	Director	Sale of securities on an exchange or to another person at price $ 3.48 per share.	07 Nov 2023	2,245	114,472	-	3.5	7,813	Common Stock, par value $0.0001 per share
Joseph Benesch	See Remarks	Sale of securities on an exchange or to another person at price $ 1.76 per share.	24 Jul 2023	4,072	63,160	-	1.8	7,167	Common Stock, par value $0.0001 per share
Claude Maraoui	Director, President & CEO	Sale of securities on an exchange or to another person at price $ 1.76 per share.	24 Jul 2023	20,767	2,127,386	-	1.8	36,550	Common Stock, par value $0.0001 per share
Miranda Jayne Toledano	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jul 2023	27,472	71,717	-		0	Common Stock, par value $0.0001 per share
Justin Smith	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jul 2023	27,472	71,717	-		0	Common Stock, par value $0.0001 per share
Jeffrey Paley	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jul 2023	27,472	71,717	-		0	Common Stock, par value $0.0001 per share
Neil Herskowitz	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jul 2023	27,472	71,717	-		0	Common Stock, par value $0.0001 per share
Claude Maraoui	Director, President & CEO	Sale of securities on an exchange or to another person at price $ 1.34 per share.	16 May 2023	24,377	2,148,153	-	1.3	32,665	Common Stock, par value $0.0001 per share
Claude Maraoui	Director, President & CEO	Sale of securities on an exchange or to another person at price $ 1.25 per share.	16 May 2023	20,000	2,172,530	-	1.3	25,000	Common Stock, par value $0.0001 per share
Joseph Benesch	Interim CFO	Sale of securities on an exchange or to another person at price $ 1.97 per share.	22 Feb 2023	2,768	67,232	-	2.0	5,453	Common Stock, par value $0.0001 per share
Justin Smith	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jul 2022	14,245	44,245	-		0	Common Stock, par value $0.0001 per share
Claude Maraoui	Director, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jul 2022	300,000	2,192,530	-		0	Common Stock, par value $0.0001 per share
Miranda Jayne Toledano	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jul 2022	14,245	44,245	-		0	Common Stock, par value $0.0001 per share
Jeffrey Paley	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jul 2022	14,245	44,245	-		0	Common Stock, par value $0.0001 per share
Neil Herskowitz	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jul 2022	14,245	44,245	-		0	Common Stock, par value $0.0001 per share
Lindsay A. Rosenwald	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jul 2022	14,245	14,245	-		0	Common Stock, par value $0.0001 per share
Jeffrey Paley	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Jan 2022	30,000	30,000	-		0	COMMON STOCK
Neil Herskowitz	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Jan 2022	30,000	30,000	-		0	COMMON STOCK
Justin Smith	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Jan 2022	30,000	30,000	-		0	COMMON STOCK
Miranda Jayne Toledano	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Jan 2022	30,000	30,000	-		0	COMMON STOCK

Showing 1 to 40 of 40 entries

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades disclosures

88.44% Gain from 52W Low

Insider Trading disclosures for Journey Medical Corp

The latest disclosure was made by Claude Maraoui in Journey Medical Corp where a trade of 49,271 Common Stock, $0.0001 par value done at an average price of $5.0 was reported to US exchanges on March 11, 2025.

Screeners based on Insider Trading and SAST parameters